RMDHealth CareFinancial Results14 August 2026· 2 min read
ResMed (ASX: RMD) Lifts FY2026 Revenue 10% as Margins Expand
ResMed lifted fiscal 2026 revenue by 10% and expanded its gross margin to 61.1%. Sleep-health demand drove growth as the company acquired Noctrix and agreed to sell MatrixCare.